Your browser doesn't support javascript.
loading
Descriptive study of adverse drug reactions in a tertiary care pediatric hospital in México from 2014 to 2017.
Morales-Ríos, Olga; Cicero-Oneto, Carlo; García-Ruiz, Carlos; Villanueva-García, Dina; Hernández-Hernández, Maribelle; Olivar-López, Víctor; Jiménez-Juárez, Rodolfo Norberto; Jasso-Gutiérrez, Luis.
Afiliación
  • Morales-Ríos O; Clinical Research Department, Hospital Infantil de México Federico Gómez, Ciudad de México, México.
  • Cicero-Oneto C; Hematological Oncology Department, Hospital Infantil de México Federico Gómez, Ciudad de México, México.
  • García-Ruiz C; Clinical Research Department, Hospital Infantil de México Federico Gómez, Ciudad de México, México.
  • Villanueva-García D; Neonatology Department, Hospital Infantil de México Federico Gómez, Ciudad de México, México.
  • Hernández-Hernández M; Intensive Therapy Department, Hospital Infantil de México Federico Gómez, Ciudad de México, México.
  • Olivar-López V; Emergency Department, Hospital Infantil de México Federico Gómez, Ciudad de México, México.
  • Jiménez-Juárez RN; Infectious Diseases Department, Hospital Infantil de México Federico Gómez, Ciudad de México, México.
  • Jasso-Gutiérrez L; Department of Pediatrics, Centro Médico Nacional La Raza, Infectious Diseases Hospital, Instituto Mexicano del Seguro Social, Ciudad de México, México.
PLoS One ; 15(3): e0230576, 2020.
Article en En | MEDLINE | ID: mdl-32208451
INTRODUCTION: In Pediatrics, adverse drug reactions (ADRs) affect morbidity and mortality. In Mexico, the characteristics of ADRs and suspect drugs have not been described in hospitalized children. OBJECTIVE: To estimate the frequency of ADRs and describe them, as well as suspect drugs, in a tertiary care pediatric hospital in Mexico. METHODS: A total of 1,649 Hospital Infantil de Mexico Federico Gómez ADR reports were analyzed. Completeness of the information was assessed, and ADRs severity and seriousness were assigned based on NOM-220-SSA1-2012, with causality being established according to the Naranjo algorithm. ADRs were classified with WHO Adverse Drug Reaction Terminology (WHO-ART). The drugs involved in ADRs were categorized according to the Anatomical Therapeutic Chemical (ATC) classification. Descriptive analysis was performed using the SPSS 20 statistical package. RESULTS: Of all the reports, 5.8% lacked sufficient information for the analysis (grade 0). ADRs frequency ranged from 2.12% to 8.07%. ADRs occurred most commonly in children (56.9%), in the female gender (52%), in subjects with normal BMI Z-score (46.6%) and malnutrition (35.3%), diagnosed with neoplasms (72.2%) and in the Emergency Department (70.0%). ADRs were severe in 14.4% of cases, in 81.0% they were serious and 2.1% were classified as definite. Most common serious ADR was febrile neutropenia (44.5%). The 0.7% of patients recovering with sequelae; 1.1% died (with the medication being associated) and 70.3% were admitted to the hospital as a result of an ADR. Antineoplastic and immunomodulating agents were more commonly associated with serious ADRs. CONCLUSION: ADRs affected morbidity and mortality, which is why strengthening pharmacovigilance programs in Mexican pediatric hospitals is necessary.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: Mexico Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: Mexico Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos